Tag Archives: Public health

Wikipedia is Also a Pharma Marketing Issue

Wikipedia is also a pharma marketing issue Writing just yesterday on this blog, Beth Bengtson, principal at healthcare marketing and communications company Hale Advisors, highlighted the problem posed for public health by Wikipedia. In her post, Beth linked back to a report on Manhattan Research’s 2009 ‘Taking the Pulse’ study that showed medical articles on […]
Posted in E-Media, Global, Guest Blog, healthcare, Marketing, multimedia, Op-Ed, social media | Also tagged , , , , | 11 Comments

PhRMA Research and Hope Awards Gives Industry a Shot in the Arm

Vaccines–once the neglected also ran in big Pharma’s armamentarium of innovations–received top billing at PhRMA’s annual Research and Hope awards held at the Washington Newseum on September 11.  More than 200 industry executives, politicians and scientists recognized the accomplishments of three separate teams in developing and building access to  preventive vaccines.
Posted in Events, healthcare, R&D | Also tagged , , , , , , , , , , , | Leave a comment

Market Access is Dead: Patient Access is the New Prescription for Healthcare Marketing

by John Glasspool Paradigms change when questions emerge the old paradigm can no longer answer. Market access has become a buzz word as access to markets is as significant a hurdle to product usage as registration itself. Initially a topic for pharmaceutical companies concerned about volume, it now affects all aspects of healthcare. We believe […]
Posted in Global, Market Access, Strategy | Also tagged , , , , , , , , | 5 Comments

Assessing the Value of Retrospective Studies: Real-World Data, Real-World Applications

by Sarah Ray The value of retrospective studies cannot be overstated. Retrospective studies affect many healthcare sectors, including the pharmaceutical industry and general public health. Applying these studies provides clear advantages at different points of the product life-cycle. During drug development, these studies may help clinical teams propose adaptations or even a companion diagnostic tests […]
Posted in Gene therapy, Global, Guest Blog, healthcare, R&D, Strategy | Also tagged , , , , , , , , , , | Leave a comment

IOM: Curb Fake Meds through Track-and-Trace, but Forget "Counterfeits"

A new report from the Institute of Medicine (IOM) has drawn a lot of attention to the public health dangers of falsified and substandard medicines around the world. The aim is to build support for a range of activities that can limit the spread of fake medicines in the U.S. and help developing nations strengthen […]
Posted in Anti-counterfeiting, compliance, Events, FDA, Manufacturing, R&D, Regulatory, Safety, Strategy, Supply Chain | Also tagged , , , , | Leave a comment
  • Categories

  • Meta